The PE Ratio as of May 2025 (TTM) for InnoCare Pharma Limited (INCPF) is -108.67

According to InnoCare Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is -108.67. This represents a change of 71.28% compared to the average of -63.45 of the last 4 quarters.

InnoCare Pharma Limited (INCPF) Historical PE Ratio (quarterly & annually)

How has INCPF PE Ratio performed in the past?

The mean historical PE Ratio of InnoCare Pharma Limited over the last ten years is -49.16. The current -108.67 PE Ratio has changed 22.01% with respect to the historical average. Over the past ten years (40 quarters), INCPF's PE Ratio was at its highest in in the September 2021 quarter at 20.71. The PE Ratio was at its lowest in in the September 2024 quarter at -211.89.

InnoCare Pharma Limited (INCPF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of InnoCare Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InnoCare Pharma Limited (INCPF) Average PE Ratio

How has INCPF PE Ratio performed in the past?

The current PE Ratio of InnoCare Pharma Limited (INCPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

InnoCare Pharma Limited (INCPF) PE Ratio vs. Peers

How is INCPF’s PE Ratio compared to its peers?

InnoCare Pharma Limited’s PE Ratio is less than Third Harmonic Bio, Inc. (-4.36), less than Passage Bio, Inc. (-0.30), less than Werewolf Therapeutics, Inc. (-0.73), less than Acrivon Therapeutics, Inc. Common Stock (-0.55), less than Eliem Therapeutics, Inc. (-1.11), less than Candel Therapeutics, Inc. (-7.30), less than PMV Pharmaceuticals, Inc. (-0.77), less than Acurx Pharmaceuticals, Inc. (-0.00), less than Monopar Therapeutics Inc. (-0.66), less than Enochian Biosciences, Inc. (-0.75), less than Kezar Life Sciences, Inc. (-0.38), less than C4 Therapeutics, Inc. (-1.00), greater than Fulcrum Therapeutics, Inc. (-829.38), less than InflaRx N.V. (-2.20), less than DiaMedica Therapeutics Inc. (-6.66), less than scPharmaceuticals Inc. (-1.95), less than Seres Therapeutics, Inc. (17.24), less than aTyr Pharma, Inc. (-2.03), less than Iovance Biotherapeutics, Inc. (-1.62),

Build a custom stock screener for InnoCare Pharma Limited (INCPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoCare Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InnoCare Pharma Limited (INCPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InnoCare Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.